Cargando…
Gadolinium-based contrast agents, erythropoietin and nephrogenic systemic fibrosis in patients with end-stage renal failure
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421164/ https://www.ncbi.nlm.nih.gov/pubmed/25983879 http://dx.doi.org/10.1093/ndtplus/sfn030 |
_version_ | 1782369806496825344 |
---|---|
author | Pieringer, Herwig Schumacher, Sabine Schmekal, Bernhard Gitter, Thomas Biesenbach, Georg |
author_facet | Pieringer, Herwig Schumacher, Sabine Schmekal, Bernhard Gitter, Thomas Biesenbach, Georg |
author_sort | Pieringer, Herwig |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4421164 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-44211642015-05-15 Gadolinium-based contrast agents, erythropoietin and nephrogenic systemic fibrosis in patients with end-stage renal failure Pieringer, Herwig Schumacher, Sabine Schmekal, Bernhard Gitter, Thomas Biesenbach, Georg NDT Plus Letters Oxford University Press 2008-06 2008-04-09 /pmc/articles/PMC4421164/ /pubmed/25983879 http://dx.doi.org/10.1093/ndtplus/sfn030 Text en © The Author [2008]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Letters Pieringer, Herwig Schumacher, Sabine Schmekal, Bernhard Gitter, Thomas Biesenbach, Georg Gadolinium-based contrast agents, erythropoietin and nephrogenic systemic fibrosis in patients with end-stage renal failure |
title | Gadolinium-based contrast agents, erythropoietin and nephrogenic systemic fibrosis in patients with end-stage renal failure |
title_full | Gadolinium-based contrast agents, erythropoietin and nephrogenic systemic fibrosis in patients with end-stage renal failure |
title_fullStr | Gadolinium-based contrast agents, erythropoietin and nephrogenic systemic fibrosis in patients with end-stage renal failure |
title_full_unstemmed | Gadolinium-based contrast agents, erythropoietin and nephrogenic systemic fibrosis in patients with end-stage renal failure |
title_short | Gadolinium-based contrast agents, erythropoietin and nephrogenic systemic fibrosis in patients with end-stage renal failure |
title_sort | gadolinium-based contrast agents, erythropoietin and nephrogenic systemic fibrosis in patients with end-stage renal failure |
topic | Letters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421164/ https://www.ncbi.nlm.nih.gov/pubmed/25983879 http://dx.doi.org/10.1093/ndtplus/sfn030 |
work_keys_str_mv | AT pieringerherwig gadoliniumbasedcontrastagentserythropoietinandnephrogenicsystemicfibrosisinpatientswithendstagerenalfailure AT schumachersabine gadoliniumbasedcontrastagentserythropoietinandnephrogenicsystemicfibrosisinpatientswithendstagerenalfailure AT schmekalbernhard gadoliniumbasedcontrastagentserythropoietinandnephrogenicsystemicfibrosisinpatientswithendstagerenalfailure AT gitterthomas gadoliniumbasedcontrastagentserythropoietinandnephrogenicsystemicfibrosisinpatientswithendstagerenalfailure AT biesenbachgeorg gadoliniumbasedcontrastagentserythropoietinandnephrogenicsystemicfibrosisinpatientswithendstagerenalfailure |